Literature DB >> 21129644

[Recommendations Onco-Urology 2010: Prostate cancer].

L Salomon1, D Azria, C Bastide, P Beuzeboc, L Cormier, F Cornud, D Eiss, P Eschwège, N Gaschignard, C Hennequin, V Molinié, P Mongiat Artus, J-L Moreau, Michel Péneau, M Peyromaure, V Ravery, X Rebillard, P Richaud, P Rischmann, F Rozet, F Staerman, A Villers, M Soulié.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21129644     DOI： 10.1016/S1166-7087(10)70042-7

Source DB:  PubMed          Journal:  Prog Urol        ISSN： 1166-7087            Impact factor:   0.915


× No keyword cloud information.
  6 in total

1.  Persistently elevated prostate-specific antigen at six weeks after radical prostatectomy helps in early identification of patients who are likely to recur.

Authors:  François Audenet; Elise Seringe; Sarah J Drouin; Eva Comperat; Olivier Cussenot; Marc-Olivier Bitker; Morgan Rouprêt
Journal:  World J Urol       Date:  2011-06-03       Impact factor: 4.226

Review 2.  DNA comparison between operative and biopsy specimens to investigate stage pT0 after radical prostatectomy.

Authors:  Thomas Bessede; Emmanuelle Girodon; Yves Allory; Annick Le Floch; Karen Leroy; Laurent Salomon
Journal:  World J Urol       Date:  2014-03-27       Impact factor: 4.226

3.  Laparoscopic sentinel lymph node (SLN) versus extensive pelvic dissection for clinically localized prostate carcinoma.

Authors:  Caroline Rousseau; Thierry Rousseau; Boumédiène Bridji; Amandine Pallardy; Jacques Lacoste; Loïc Campion; Aude Testard; Geneviève Aillet; Ayat Mouaden; Chantal Curtet; Françoise Kraeber-Bodéré
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-16       Impact factor: 9.236

4.  Feasibility, safety, and efficacy of salvage radical prostatectomy after Tookad® Soluble focal treatment for localized prostate cancer.

Authors:  Souhil Lebdai; Arnaud Villers; Eric Barret; Cosmina Nedelcu; Pierre Bigot; Abdel-Rahmène Azzouzi
Journal:  World J Urol       Date:  2015-01-23       Impact factor: 4.226

5.  Screening for Prostate Cancer by Digital Rectal Examination and PSA Determination in Senegal.

Authors:  Lamine Niang; Charles N Kouka; Mohamed Jalloh; Sérigne M Gueye
Journal:  ISRN Oncol       Date:  2011-07-10

6.  Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival.

Authors:  Sophie Robin; Sylvie Chabaud; Anne-Agathe Serre; Béatrice Bringeon; Sébastien Clippe; François Rocher; Olivier Desmettre; Gabriel Bringeon; Frédéric Gassa; Pascal Pommier
Journal:  J Contemp Brachytherapy       Date:  2021-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.